MeridianConsensus
Operator profileBSXMarlborough, MAData as of May 2026

Boston Scientific

Boston Scientific is worldwide developer, manufacturer and marketer of medical devices. Founded in 1984. (Wikidata)

Boston Scientific's strongest tracked position is the Interventional Cardiology Market at an estimated 18.0% share in a market growing at 6.3% CAGR. Average estimated share across all tracked markets is 16.5%, indicating a concentrated leadership position.

Meridian Consensus tracks Boston Scientific in 2 markets across 1 industry (Healthcare). Estimated in-market revenue is $3.6B, the sum of share × market size across appearances — a modeled figure, not reported company revenue.

Filed financials · SEC 10-K · FY2025

EDGAR · CIK 885725
Revenue (filed)
$20.1B
Net income (filed)
Total assets (filed)
$43.7B

Exchange-filed figures from SEC XBRL companyfacts (BOSTON SCIENTIFIC CORP). The modeled in-market estimates below cover only the markets Meridian tracks and will not sum to filed revenue.

Markets tracked
2
Industries
1
Est. in-market revenue
$3.6B
Top market share
18.0%

Share and revenue figures are Meridian model estimates reconciled through the publish-gate validator, not audited financials. Methodology

Market positions

Avg share 16.5% · sorted by est. revenue
MarketCAGRShare
Interventional Cardiology Market6.3%18.0%
Thrombus Aspiration Catheter Market8.1%15.0%
Est. revenue by market (share × market size)
Interventional Cardiology$3.3B
Thrombus Aspiration Catheter$294M

Meridian Dossier

Need diligence-grade depth on Boston Scientific?

Commission a source-cited diligence dossier on Boston Scientific: identity, filed financials, IP, litigation, and government exposure. Free preview first, from $299.

Boston Scientific: frequently asked

Meridian Consensus tracks Boston Scientific in 2 markets: Interventional Cardiology Market ($18.5B), Thrombus Aspiration Catheter Market ($2.0B), spanning Healthcare.

Boston Scientific's strongest tracked position is the Interventional Cardiology Market, a $18.5B market growing at 6.3% CAGR, where it holds an estimated 18.0% share as of May 2026.

Across Meridian-tracked markets, Boston Scientific's closest peers are Terumo Corporation, Teleflex, Medtronic plc, Meril Life Sciences, Abbott Laboratories, with the largest overlap in the Interventional Cardiology Market. Peer mapping is based on co-appearance in the same tracked markets.

No. Share and revenue figures on this page are model estimates produced by Meridian's research pipeline and committee-reviewed before publication; they are not audited or exchange-filed financials. Market-level sizings are reconciled against external sources during the publish gate.

Adjacent markets in Healthcare

Tracked markets in the same industry where Boston Scientific is not among the named operators. Each carries Porter Five Forces, SWOT, country analysis, and a full competitor table.

Operators that compete with Boston Scientific

Meridian Consensus Digest

Free · Weekly

Not ready to commission a full report? Get our weekly briefing instead: new market sizings, thesis revisions, and reconciliation updates. Signed by the research team. No sales emails.

Subscribed by teams in Corporate Development, PE, and Management Consulting. Unsubscribe in one click.